Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Technology

January 18, 2013 — nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s ...

Home January 18, 2013
Home
News

January 8, 2013 — The results of a recent study presented yesterday at the American Heart Association Scientific ...

Home January 08, 2013
Home
News

November 15, 2012 — The U.S. Patent and Trademark Office has awarded Biomedical Systems U.S. Patent Number 8301236 for ...

Home November 15, 2012
Home
News

November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...

Home November 09, 2012
Home
Technology

October 8, 2012 — The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments ...

Home October 08, 2012
Home
News

October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...

Home October 02, 2012
Home
News

October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...

Home October 01, 2012
Home
News

September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to ...

Home September 19, 2012
Home
News

September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...

Home September 13, 2012
Home
Feature

September 11, 2012 — Since the previous consensus document was published in 2007, catheter and surgical ablation of atri ...

Home September 11, 2012
Home
Feature

September 10, 2012 — Atrial fibrillation (AF) is a common complication of cardiac surgery, occurring in 10 to 40 percent ...

Home September 10, 2012
Home
Feature

August 30, 2012 — Baseline data from the first cohort of the Global Anticoagulant Registry in the Field (GARFIELD), an ...

Home August 30, 2012
Home
Feature

August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge ...

Home August 20, 2012
Home
Feature

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and ...

Home July 26, 2012
Home
Feature | Marianne Pop, Pharm.D., BCPS

Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...

Home July 12, 2012
Home
Subscribe Now